Dose Escalation Study of a PD1-LAG3 Bispecific Antibody in Patients With Advanced and/or Metastatic Solid Tumors
Hoffmann-La Roche
Hoffmann-La Roche
AstraZeneca
Genmab
Seagen Inc.
BioNTech SE
Hoffmann-La Roche
Psyence Australia Pty Ltd
Neonc Technologies, Inc.
ViroMissile, Inc.
Erasca, Inc.
Ipsen
AstraZeneca
Pfizer
Arvinas Inc.
Tizona Therapeutics, Inc
Aulos Bioscience, Inc.
Genentech, Inc.
USWM, LLC (dba US WorldMeds)
MacroGenics
DualityBio Inc.
MacroGenics
xCures
Daiichi Sankyo
Beijing Tide Pharmaceutical Co., Ltd
IDEAYA Biosciences
Conjupro Biotherapeutics, Inc.
Pfizer
Second Life Therapeutics
ImmunityBio, Inc.
AgonOx, Inc.
Elephas
Innate Pharma
Novartis
Elephas
Amgen
Linnaeus Therapeutics, Inc.
Inhibrx Biosciences, Inc
Incyte Corporation
GV20 Therapeutics
NeoTX Therapeutics Ltd.
AccSalus Biosciences, Inc.
HiFiBiO Therapeutics
HiFiBiO Therapeutics
DualityBio Inc.
Bolt Biotherapeutics, Inc.
AstraZeneca
Bayer
Revolution Medicines, Inc.
GlaxoSmithKline
Tempus AI